Free Trial

ImmunityBio (IBRX) SEC Filings & 10K Form

$3.50
-0.08 (-2.23%)
(As of 03:25 PM ET)

Recent ImmunityBio SEC Filings

DateFilerForm TypeView
08/12/2024
7:03 AM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/17/2024
8:48 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
3:51 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/13/2024
5:49 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
MAXWELL LINDA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:49 PM
BLASZYK MICHAEL D (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:49 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Selecky Christobel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:49 PM
Cohen Cheryl (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:49 PM
Clark Wesley (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:50 PM
Brennan John Owen (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
3:36 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
4:00 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2024
11:15 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form EFFECT
04/29/2024
3:18 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form DEF 14A
04/29/2024
3:20 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form DEFA14A
04/23/2024
5:17 AM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
4:24 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form S-3ASR
03/28/2024
8:14 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/19/2024
3:31 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2024
3:40 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Sachs David C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
3:41 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
LAUER REGAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
3:43 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Simon Barry J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
3:36 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
SOON-SHIONG PATRICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
3:38 PM
Adcock Richard (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
8:28 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2024
8:14 PM
Adcock Richard (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:38 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Simon Barry J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:32 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
LAUER REGAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:33 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Sachs David C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
8:59 PM
Cambridge Equities, LP (Filed by)
ImmunityBio, Inc. (Subject)
ImmunityBio (Subject)
Form SC 13D/A
01/03/2024
8:53 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Nant Capital, LLC (Reporting)
SOON-SHIONG PATRICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
8:40 PM
Adcock Richard (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
8:41 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Sachs David C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
5:08 AM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2023
3:41 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
LAUER REGAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
8:28 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/28/2023
5:06 AM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form DEF 14C
09/22/2023
2:06 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form D
Notice of Exempt Offering of Securities 
09/21/2023
3:25 PM
Cambridge Equities, LP (Filed by)
ImmunityBio, Inc. (Subject)
ImmunityBio (Subject)
Form SC 13D/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:IBRX) was last updated on 9/16/2024 by MarketBeat.com Staff

From Our Partners